BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6225150)

  • 1. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zimelidine and amitriptyline in the treatment of depressive illness in general practice.
    Loudon JB; Tiplady B; Ashcroft GW; Waddell JL
    Acta Psychiatr Scand Suppl; 1981; 290():454-63. PubMed ID: 6452805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 7. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zimeldine tolerability in comparison to amitriptyline and placebo: findings from a multicentre trial.
    Claghorn J; Gershon S; Goldstein BJ
    Acta Psychiatr Scand Suppl; 1983; 308():104-14. PubMed ID: 6230883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cardiovascular effects of amitriptyline and zimelidine using thoracic impedance cardiography.
    Christie JE; Brown D
    Acta Psychiatr Scand Suppl; 1981; 290():385-92. PubMed ID: 6452802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind study comparing the efficacy of zimelidine and amitriptyline in endogenous depression.
    O'Connor M; Grigor J
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):127-32. PubMed ID: 6233635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zimelidine: comparison of different dosage regimes in general practice.
    Watson JM; Tiplady B
    Acta Psychiatr Scand Suppl; 1981; 290():464-70. PubMed ID: 6452806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
    d'Elia G; Hällström T; Nyström C; Ottosson JO
    Acta Psychiatr Scand Suppl; 1981; 290():225-35. PubMed ID: 6452793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open trial of zimelidine in patients with endogenous depression.
    Kiloh LG; Moore G
    Int Pharmacopsychiatry; 1982; 17(1):28-35. PubMed ID: 6211416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zimelidine: a second generation antidepressant. A report from the general practitioner research group.
    Practitioner; 1982 Sep; 226(1371):1625-8. PubMed ID: 6216471
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidepressant efficacy of zimelidine and maprotiline.
    Montgomery SA; Rani SJ; McAuley R; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():219-24. PubMed ID: 6452792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.